In adults inhaling salbutamol via metered-dose inhalers (MDIs) 200 mu
g doses are recommended, but with diskhalers the manufacturer advocate
s 400 rather than 200 mu g doses. To assess this advice, a partially d
ouble-blind, placebo-controlled salbutamol dose response, crossover st
udy (also incorporating MDI doses) was conducted in 12 mild/moderate a
sthmatics. After active treatment, mean peak expiratory flow rate (PEF
R) increments yielded no clinically or statistically significant diffe
rences; compared to placebo, respective median differences in PEFR inc
rements (95% CIs) were 10(-10, 50), 20 (0, 50), and 15 (0, 30) followi
ng 400 and 200 mu g via diskhalers and 200 mu g via MDIs. Diskhalers a
re a suitable alternative for patients with poor MDI technique, but th
e use of 400 rather than 200 mu g salbutamol doses is not supported by
evidence.